310 related articles for article (PubMed ID: 36466844)
1. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
3. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
4. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
5. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
6. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
Front Immunol; 2022; 13():964118. PubMed ID: 36059470
[TBL] [Abstract][Full Text] [Related]
7. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
Front Immunol; 2022; 13():999084. PubMed ID: 36544770
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis of Necroptosis-Related Genes for Prognosis, Immune Microenvironment Infiltration, and Drug Sensitivity in Colon Cancer.
He R; Zhang M; He L; Huang J; Man C; Wang X; Lang Y; Fan Y
Front Med (Lausanne); 2022; 9():845271. PubMed ID: 35479956
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer.
Zhang F; Qi C; Yao Z; Xu H; Zhou G; Li C; Xia H
Apoptosis; 2023 Dec; 28(11-12):1628-1645. PubMed ID: 37787960
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
[TBL] [Abstract][Full Text] [Related]
11. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
12. A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing.
Guo K; Duan X; Zhao J; Sun B; Liu X; Zhao Z
Front Mol Biosci; 2022; 9():984712. PubMed ID: 36111134
[No Abstract] [Full Text] [Related]
13. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma.
Zhou Z; Xu J; Huang N; Tang J; Ma P; Cheng Y
Front Oncol; 2022; 12():855434. PubMed ID: 35719998
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
16. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
17. Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma.
Zhang G; Chen R; Zhu L; Ma H; Tang H; Shang C; Wang J; Zhang D; Li Q; Liu J
Comput Math Methods Med; 2022; 2022():3440586. PubMed ID: 36110575
[TBL] [Abstract][Full Text] [Related]
18. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
[TBL] [Abstract][Full Text] [Related]
19. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]